Combination of Eltrombopag With Immunosuppressive Therapy in East-Asian Patients With Severe Aplastic Anemia

Condition:   Severe Aplastic Anemia (SAA) Interventions:   Drug: eltrombopag;   Drug: rabbit anti-thymocyte globulin (r-ATG);   Drug: cyclosporine A (CsA) Sponsor:   Novartis Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials